Autocrine PDGF stimulation in malignancies

References

• Heldin C-H, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79:1283–316.
   PubMed Web of Science ®Google Scholar
• Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22:1276–312.
   PubMed Web of Science ®Google Scholar
• Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet. 1992;339:23–5.
   PubMed Web of Science ®Google Scholar
• Rodt SÅ, Åhlén K, Berg A, Rubin K, Reed RK. A novel physiological function for platelet-derived growth factor-BB in rat dermis. J Physiol. 1996;495:193–200.
   PubMed Web of Science ®Google Scholar
• Antoniades HN, Scher CD, Stiles CD. Purification of human platelet-derived growth factor. Proc Natl Acad Sci USA. 1979;76:1809–12.
   PubMed Web of Science ®Google Scholar
• Deuel TF, Huang JS, Proffitt RT, Baenziger JU, Chang D, Kennedy BB. Human platelet-derived growth factor: purification and resolution into two active protein fractions. J Biol Chem. 1981;256:8896–9.
   PubMed Web of Science ®Google Scholar
• Heldin C-H, Westermark B, Wasteson Å. Platelet-derived growth factor: purification and partial characterization. Proc Natl Acad Sci USA. 1979;76:3722–6.
   PubMed Web of Science ®Google Scholar
• Raines EW, Ross R. Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. J Biol Chem. 1982;257:5154–60.
   PubMed Web of Science ®Google Scholar
• Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson Å, Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature. 1983;304:35–9.
   PubMed Web of Science ®Google Scholar
• Doolittle RF, Hunkapiller MW, Hood LE, Devare SD, Robbins KC, Aaronson SA, Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science. 1983;221:275–7.
   PubMed Web of Science ®Google Scholar
• Deuel TF, Huang JS, Huang SS, Stroobant P, Waterfield MD. Expression of a platelet-derived growth factor-like protein in simian sarcoma virus transformed cells. Science. 1983;221:1348–50.
   PubMed Web of Science ®Google Scholar
• Johnsson A, Betsholtz C, von der Helm K, Heldin C-H, Westermark B. Platelet-derived growth factor agonist activity of a secreted form of the v-sis oncogene product. Proc Natl Acad Sci USA. 1985;82:1721–5.
   PubMed Web of Science ®Google Scholar
• Johnsson A, Betsholtz C, Heldin C-H, Westermark B. Antibodies against platelet-derived growth factor inhibit acute transformation by simian sarcoma virus. Nature. 1985;317:438–40.
   PubMed Web of Science ®Google Scholar
• Heldin C-H, Westermark B. Growth factors: mechanism of action and relation to oncogenes. Cell. 1984;37:9–20.
   PubMed Web of Science ®Google Scholar
• Temin HM, Pierson RW Jr, Dulak NC. The role of serum in the control of multiplication of avian and mammalian cells in culture. In Rothblatt GH, Cristofalo VJ, editors. Growth, nutrition and metabolism of cells in culture. New York: Academic Press; 1972. p 50–81.
   Google Scholar
• Heldin C-H, Westermark B, Wasteson Å. Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: resemblance with platelet-derived growth factor. J Cell Physiol. 1980;105:235–46.
   PubMed Web of Science ®Google Scholar
• Westermark B, Wasteson Å. The response of cultured normal glial cells to growth factors. In Luft R, Hall K, editors. Advances in metabolic disorders. New York: Academic Press; 1975. p 85–100.
   Google Scholar
• Heldin C-H, Johnsson A, Wennergren S, Wernstedt C, Betsholtz C, Westermark B. A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature. 1986;319:511–14.
   PubMed Web of Science ®Google Scholar
• Betsholtz C, Westermark B, Ek B, Heldin C-H. Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: implications for autocrine receptor activation. Cell. 1984;39:447–57.
   PubMed Web of Science ®Google Scholar
• Nistér M, Libermann TA, Betsholtz C, Pettersson M, Claesson-Welsh L, Heldin C-H, Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-α and their receptors in human malignant glioma cell lines. Cancer Res. 1988;48:3910–18.
   PubMed Web of Science ®Google Scholar
• Nistér M, Claesson-Welsh L, Eriksson A, Heldin C-H, Westermark B. Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. J Biol Chem. 1991;266:16755–63.
   PubMed Web of Science ®Google Scholar
• Vassbotn FS, Östman A, Langeland N, Holmsen H, Westermark B, Heldin C-H, Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line. J Cell Physiol. 1994;158:381–9.
   PubMed Web of Science ®Google Scholar
• Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 2001;15:1913–25.
   PubMed Web of Science ®Google Scholar
• Shamah SM, Stiles CD, Guha A. Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Mol Cell Biol. 1993;13:7203–12.
   PubMed Web of Science ®Google Scholar
• Guha A, Dashner K, Black PM, Wagner JA, Stiles CD. Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer. 1995;60:168–73.
   PubMed Web of Science ®Google Scholar
• Hermanson M, Nistér M, Betsholtz C, Heldin C-H, Westermark B, Funa K. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growh factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci USA. 1988;85:7748–52.
   PubMed Web of Science ®Google Scholar
• Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin C-H, Westermark B, Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 1992;52:3213–19.
   PubMed Web of Science ®Google Scholar
• Lokker NA, Sullivan CM, Hollenbach SJ, Israel MA, Giese NA. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res. 2002;62:3729–35.
   PubMed Web of Science ®Google Scholar
• Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET, Black PM, Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest. 1990;86:131–40.
   PubMed Web of Science ®Google Scholar
• Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One. 2009;4:e7752.
   PubMed Web of Science ®Google Scholar
• Lindberg N, Holland E. PDGF in gliomas: more than just a growth factor? Ups J Med Sci. 2012;117:92–8.
   PubMed Web of Science ®Google Scholar
• Smits A, Funa K, Vassbotn FS, Beausang-Linder M, af Ekenstam F, Heldin C-H, Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin. Am J Pathol. 1992;140:639–48.
   PubMed Web of Science ®Google Scholar
• Wang J, Coltrera MD, Gown AM. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: an immunohistochemical and in situ hybridization study. Cancer Res. 1994;54:560–4.
   PubMed Web of Science ®Google Scholar
• Stürzl M, Roth WK, Brockmeyer NH, Zietz C, Speiser B, Hofschneider PH. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci USA. 1992;89:7046–50.
   PubMed Web of Science ®Google Scholar
• Maxwell M, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN. Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products. Int J Cancer. 1990;46:16–21.
   PubMed Web of Science ®Google Scholar
• Todo T, Adams EF, Fahlbusch R, Dingermann T, Werner H. Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor. J Neurosurg. 1996;84:852–8.
   PubMed Web of Science ®Google Scholar
• Yang J, Liu X, Nyland SB, Zhang R, Ryland LK, Broeg K, Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway. Blood. 2010;115:51–60.
   PubMed Web of Science ®Google Scholar
• Ghanem M, Nijman R, Safan M, van der Kwast T, Vansteenbrugge G. Expression and prognostic value of platelet-derived growth factor-AA and its receptor α in nephroblastoma. BJU Int. 2010;106:1389–93.
   PubMed Web of Science ®Google Scholar
• McDermott U, Ames RY, Iafrate AJ, Maheswaran S, Stubbs H, Greninger P, Ligand-dependent platelet-derived growth factor receptor (PDGFR)-α activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors. Cancer Res. 2009;69:3937–46.
   PubMed Web of Science ®Google Scholar
• Taniguchi E, Nishijo K, McCleish AT, Michalek JE, Grayson MH, Infante AJ, PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma. Oncogene. 2008;27:6550–60.
   PubMed Web of Science ®Google Scholar
• Armistead PM, Salganick J, Roh JS, Steinert DM, Patel S, Munsell M, Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patients. Cancer. 2007;110:2293–303.
   PubMed Web of Science ®Google Scholar
• O'Brien KP, Seroussi E, Dal Cin P, Sciot R, Mandahl N, Fletcher JA, Various regions within the α-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas. Gene Chrom Cancer. 1998;23:187–93.
   PubMed Web of Science ®Google Scholar
• Shimizu A, O'Brien KP, Sjöblom T, Pietras K, Buchdunger E, Collins VP, The dermatofibrosarcoma protuberans-associated collagen type Iα1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res. 1999;59:3719–23.
   PubMed Web of Science ®Google Scholar
• Simon M-P, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre J-M, Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet. 1997;15:95–8.
   PubMed Web of Science ®Google Scholar
• Sjöblom T, Shimizu A, O'Brien KP, Pietras K, Dal Cin P, Buchdunger E, Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res. 2001;61:5778–83.
   PubMed Web of Science ®Google Scholar
• Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev. 2004;15:197–204.
   PubMed Web of Science ®Google Scholar
• Ustach CV, Kim HR. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells. Mol Cell Biol. 2005;25:6279–88.
   PubMed Web of Science ®Google Scholar
• Keating MT, Williams LT. Autocrine stimulation of intracellular PDGF receptors in v-sis transformed cells. Science. 1988;239:914–16.
   PubMed Web of Science ®Google Scholar
• Huang SS, Huang JS. Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation. J Biol Chem. 1988;263:12608–18.
   PubMed Web of Science ®Google Scholar
• Bejcek BE, Li DY, Deuel TF. Transformation by v-sis occurs by an internal autoactivation mechanism. Science. 1989;245:1496–9.
   PubMed Web of Science ®Google Scholar
• Betsholtz C, Johnsson A, Heldin C-H, Westermark B. Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc Natl Acad Sci USA. 1986;83:6440–4.
   PubMed Web of Science ®Google Scholar
• Hannink M, Donoghue DJ. Autocrine stimulation by the v-sis gene product requires a ligand-receptor interaction at the cell surface. J Cell Biol. 1988;107:287–98.
   PubMed Web of Science ®Google Scholar
• Huang JS, Huang SS, Deuel TF. Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors. Cell. 1984;39:79–87.
   PubMed Web of Science ®Google Scholar
• Valgeirsdóttir S, Eriksson A, Nistér M, Heldin C-H, Westermark B, Claesson-Welsh L. Compartmentalization of autocrine signal transduction pathways in Sis transformed NIH 3T3 cells. J Biol Chem. 1995;270:10161–70.
   PubMed Web of Science ®Google Scholar
• Afrakhte M, Nistér M, Östman A, Westermark B, Paulsson Y. Production of cell-associated PDGF-AA by a human sarcoma cell line: evidence for a latent autocrine effect. Int J Cancer. 1996;68:802–9.
   PubMed Web of Science ®Google Scholar
• Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellström M, Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 2003;17:1835–40.
   PubMedGoogle Scholar
• Ehnman M, Li H, Fredriksson L, Pietras K, Eriksson U. The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth. Oncogene. 2009;28:534–44.
   PubMed Web of Science ®Google Scholar
• Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 1994;77:307–16.
   PubMed Web of Science ®Google Scholar
• Magnusson MK, Meade KE, Brown KE, Arthur DC, Krueger LA, Barrett AJ, Rabaptin-5 is a novel fusion partner to platelet-derived growth factor β receptor in chronic myelomonocytic leukemia. Blood. 2001;98:2518–25.
   PubMed Web of Science ®Google Scholar
• Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348:1201–14.
   PubMed Web of Science ®Google Scholar
• Griffin JH, Leung J, Bruner RJ, Caligiuri MA, Briesewitz R. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci USA. 2003;100:7830–5.
   PubMed Web of Science ®Google Scholar
• Pardanani A, Ketterling RP, Brockman SR, Flynn HC, Paternoster SF, Shearer BM, CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood. 2003;102:3093–6.
   PubMed Web of Science ®Google Scholar
• Stover EH, Chen J, Folens C, Lee BH, Mentens N, Marynen P, Activation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independent. Proc Natl Acad Sci USA. 2006;103:8078–83.
   PubMed Web of Science ®Google Scholar
• Toffalini F, Hellberg C, Demoulin J-B. Critical role of the platelet-derived growth factor receptor (PDGFR) β transmembrane domain in the TEL-PDGFRβ cytosolic oncoprotein. J Biol Chem. 2010;285:12268–78.
   PubMed Web of Science ®Google Scholar
• Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299:708–10.
   PubMed Web of Science ®Google Scholar
• Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res. 1992;52:4550–3.
   PubMed Web of Science ®Google Scholar
• Kumabe T, Sohma Y, Kayama T, Yoshimoto T, Yamamoto T. Amplification of platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin. Oncogene. 1992;7:627–33.
   PubMed Web of Science ®Google Scholar
• Puputti M, Tynninen O, Sihto H, Blom T, Maenpaa H, Isola J, Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas. Mol Cancer Res. 2006;4:927–34.
   PubMed Web of Science ®Google Scholar
• Smith JS, Wang XY, Qian J, Hosek SM, Scheithauer BW, Jenkins RB, Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J Neuropathol Exp Neurol. 2000;59:495–503.
   PubMed Web of Science ®Google Scholar
• Arai H, Ueno T, Tangoku A, Yoshino S, Abe T, Kawauchi S, Detection of amplified oncogenes by genome DNA microarrays in human primary esophageal squamous cell carcinoma: comparison with conventional comparative genomic hybridization analysis. Cancer Genet Cytogenet. 2003;146:16–21.
   PubMedGoogle Scholar
• Zhao J, Roth J, Bode-Lesniewska B, Pfaltz M, Heitz PU, Komminoth P. Combined comparative genomic hybridization and genomic microarray for detection of gene amplifications in pulmonary artery intimal sarcomas and adrenocortical tumors. Genes Chromosomes Cancer. 2002;34:48–57.
   PubMed Web of Science ®Google Scholar
• Clarke ID, Dirks PB. A human brain tumor-derived PDGFR-alpha deletion mutant is transforming. Oncogene. 2003;22:722–33.
   PubMed Web of Science ®Google Scholar
• Östman A, Heldin C-H. Involvement of platelet-derived growth factor in disease: development of specific antagonists. Adv Cancer Res. 2001;80:1–38.
   PubMed Web of Science ®Google Scholar
• Maki RG, Awan RA, Dixon RH, Jhanwar S, Antonescu CR. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int J Cancer. 2002;100:623–6.
   PubMed Web of Science ®Google Scholar
• McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Rychter M, Corless CL, Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol. 2005;23:866–73.
   PubMed Web of Science ®Google Scholar
• Rubin BP, Schuetze SM, Eary JF, Norwood TH, Mirza S, Conrad EU, Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol. 2002;20:3586–91.
   PubMed Web of Science ®Google Scholar
• Apperley JF, Gardembas M, Melo JV, Russell-Jones R, Bain BJ, Baxter EJ, Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med. 2002;347:481–7.
   PubMed Web of Science ®Google Scholar
• Magnusson MK, Meade KE, Nakamura R, Barrett J, Dunbar CE. Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor receptor fusion oncogene. Blood. 2002;100:1088–91.
   PubMed Web of Science ®Google Scholar
• Gleich GJ, Leiferman KM, Pardanani A, Tefferi A, Butterfield JH. Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet. 2002;359:1577–8.
   PubMed Web of Science ®Google Scholar
• Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol. 2003;21:4342–9.
   PubMed Web of Science ®Google Scholar
• Kilic T, Alberta JA, Zdunek PR, Acar M, Iannarelli P, O'Reilly T, Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res. 2000;60:5143–50.
   PubMed Web of Science ®Google Scholar
• Uhrbom L, Hesselager G, Östman A, Nistér M, Westermark B. Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells. Int J Cancer. 2000;85:398–406.
   PubMed Web of Science ®Google Scholar
• Pietras K, Sjöblom T, Rubin K, Heldin C-H, Östman A. PDGF receptors as cancer drug targets. Cancer Cell. 2003;3:439–43.
   PubMed Web of Science ®Google Scholar
• Uhrbom L, Hesselager G, Nistér M, Westermark B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 1998;58:5275–9.
   PubMed Web of Science ®Google Scholar
• Johansson FK, Brodd J, Eklof C, Ferletta M, Hesselager G, Tiger CF, Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging. Proc Natl Acad Sci USA. 2004;101:11334–7.
   PubMed Web of Science ®Google Scholar
• Johansson FK, Goransson H, Westermark B. Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene. 2005;24:3896–905.
   PubMed Web of Science ®Google Scholar
• Swartling FJ, Ferletta M, Kastemar M, Weiss WA, Westermark B. Cyclic GMP dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene. 2009;28:3121–31.
   PubMed Web of Science ®Google Scholar
• Ferletta M, Uhrbom L, Olofsson T, Ponten F, Westermark B. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B-induced gliomagenesis. Mol Cancer Res. 2007;5:891–7.
   PubMed Web of Science ®Google Scholar
• Tchougounova E, Jiang Y, Brasater D, Lindberg N, Kastemar M, Asplund A, Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence. Oncogene. 2009;28:1537–48.
   PubMed Web of Science ®Google Scholar
• Wolf RM, Draghi N, Liang X, Dai C, Uhrbom L, Eklof C, p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3. Genes Dev. 2003;17:476–87.
   Google Scholar
• Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst. 1998;90:1473–9.
   PubMed Web of Science ®Google Scholar
• Bigner SH, Rasheed BK, Wiltshire R, McLendon RE. Morphologic and molecular genetic aspects of oligodendroglial neoplasms. Neuro Oncol. 1999;1:52–60.
   PubMedGoogle Scholar
• Tchougounova E, Kastemar M, Brasater D, Holland EC, Westermark B, Uhrbom L. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma. Oncogene. 2007;26:6289–96.
   PubMed Web of Science ®Google Scholar
• Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–90.
   PubMed Web of Science ®Google Scholar
• Jechlinger M, Grunert S, Tamir IH, Janda E, Ludemann S, Waerner T, Expression profiling of epithelial plasticity in tumor progression. Oncogene. 2003;22:7155–69.
   PubMed Web of Science ®Google Scholar
• Jechlinger M, Sommer A, Moriggl R, Seither P, Kraut N, Capodiecci P, Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest. 2006;116:1561–70.
   PubMed Web of Science ®Google Scholar
• Seymour L, Dajee D, Bezwoda WR. Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer. Breast Cancer Res Treat. 1993;26:247–52.
   PubMed Web of Science ®Google Scholar
• Kawai T, Hiroi S, Torikata C. Expression in lung carcinomas of platelet-derived growth factor and its receptors. Lab Invest. 1997;77:431–6.
   PubMed Web of Science ®Google Scholar
• Gotzmann J, Fischer AN, Zojer M, Mikula M, Proell V, Huber H, A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene. 2006;25:3170–85.
   PubMed Web of Science ®Google Scholar
• Lau CK, Yang ZF, Ho DW, Ng MN, Yeoh GC, Poon RT, An Akt/hypoxia-inducible factor-1α/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Clin Cancer Res. 2009;15:3462–71.
   PubMed Web of Science ®Google Scholar
• Ustach CV, Huang W, Conley-LaComb MK, Lin CY, Che M, Abrams J, A novel signaling axis of matriptase/PDGF-D/ss-PDGFR in human prostate cancer. Cancer Res. 2010;70:9631–40.
   PubMed Web of Science ®Google Scholar
• Kong D, Li Y, Wang Z, Banerjee S, Ahmad A, Kim HR, Mir-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells. 2009;27:1712–21.
   PubMed Web of Science ®Google Scholar
• Dolloff NG, Shulby SS, Nelson AV, Stearns ME, Johannes GJ, Thomas JD, Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by alpha platelet-derived growth factor receptor. Oncogene. 2005;24:6848–54.
   PubMed Web of Science ®Google Scholar
• Russell MR, Jamieson WL, Dolloff NG, Fatatis A. The receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells. Oncogene. 2009;28:412–21.
   PubMed Web of Science ®Google Scholar
• Russell MR, Liu Q, Lei H, Kazlauskas A, Fatatis A. The receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms. Cancer Res. 2010;70:4195–203.
   PubMed Web of Science ®Google Scholar
• Erlandsson A, Brannvall K, Gustafsdottir S, Westermark B, Forsberg-Nilsson K. Autocrine/paracrine platelet-derived growth factor regulates proliferation of neural progenitor cells. Cancer Res. 2006;66:8042–8.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Boije M, Westermark B, Uhrbom L. PDGF-B Can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation. Neoplasia. 2011;13:492–503.
   Google Scholar